Related Experiment Video
Updated: Oct 9, 2025
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
Published on: April 25, 2014
Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm
Yoichi Fujita1, Seiko Hirono1, Manabu Kawai1
1Second Department of Surgery, School of Medicine, Wakayama Medical University, Japan.
Background:
As the malignant potential of main duct (MD-) type intraductal papillary mucinous neoplasm (IPMN) has been discussed together with Mixed-type in most previous studies, the malignant potential of pure MD-type IPMN remains unclear. This study evaluated the specific characteristics and predictors of high-grade dysplasia (HGD) and invasive intraductal papillary mucinous carcinoma (IPMC) for pure MD-type IPMN.
Methods:
From 1,100 patients with IPMN, this study includes 387 patients that underwent surgery. We evaluated the specific characteristics of pure MD-type IPMN by comparing clinicopathological factors between MD-type (n = 79) and branch duct (BD-) type (n = 146) or Mixed-type IPMN (n = 162), and predictors of HGD/invasive IPMC in pure MD-type IPMN.
Results:
The rate of HGD/invasive IPMC was significantly higher in MD-type than in BD-type (70.9 vs. 48.6%, P = 0.001), although there was no difference between MD-type and Mixed-type IPMNs (P = 0.343). Recurrence-free survival (RFS) and disease-specific survival (DSS) of patients with MD-type were better than those of patients with Mixed-type (P = 0.008 and P = 0.009, respectively). There were no significant differences in RFS, overall survival, and DSS between patients with MD-type and patients with BD-type IPMNs. Multivariate analysis showed two independent predictors of HGD/invasive IPMC in MD-type IPMN; mural nodule height ≥5 mm (P = 0.025, odds ratio [OR]; 16.949) and carcinoembryonic antigen (CEA) level in the pancreatic juice obtained by preoperative endoscopic retrograde pancreatography ≥50 ng/ml (P = 0.039, OR; 9.091).
Conclusions:
Measurement of mural nodule height and CEA in the pancreatic juice might be useful in determining surgical indication for pure MD-type IPMN, although further studies for confirmation are essential.
Insights
Pure main duct (MD)-type intraductal papillary mucinous neoplasm (IPMN) has a high rate of high-grade dysplasia and invasive carcinoma. Mural nodule height and CEA levels predict malignancy in MD-IPMN, aiding surgical decisions.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pathology
Background:
- The malignant potential of main duct (MD)-type intraductal papillary mucinous neoplasm (IPMN) is not well-defined, often studied alongside mixed-type IPMN.
- Previous research has not specifically isolated the characteristics and malignant potential of pure MD-type IPMN.
Purpose of the Study:
- To evaluate the specific characteristics of pure MD-type IPMN.
- To identify predictors of high-grade dysplasia (HGD) and invasive IPMC in pure MD-type IPMN.
Main Methods:
- Comparative analysis of clinicopathological factors in 387 surgically treated IPMN patients.
- Comparison between MD-type (n=79), branch duct (BD)-type (n=146), and mixed-type IPMN (n=162).
- Multivariate analysis to identify independent predictors of HGD/invasive IPMC in pure MD-type IPMN.
Main Results:
- MD-type IPMN showed a significantly higher rate of HGD/invasive IPMC compared to BD-type (70.9% vs. 48.6%).
- Recurrence-free survival and disease-specific survival were better for MD-type than mixed-type IPMN.
- Mural nodule height ≥5 mm and pancreatic juice CEA level ≥50 ng/ml were independent predictors of HGD/invasive IPMC in MD-type IPMN.
Conclusions:
- Mural nodule height and CEA levels in pancreatic juice are potential indicators for surgical intervention in pure MD-type IPMN.
- Further studies are needed to confirm these findings and refine surgical indications.
Related Concept Videos
02:23Abnormal Proliferation
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...